Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Friday. The firm issued a sell rating on the stock. Ampio Pharmaceuticals Stock Performance Shares of NYSE AMPE opened at $0.00 on Friday. The stock has a market capitalization of $2,951.00, a PE ratio of 0.00 and […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Downgrades Meritage Homes (NYSE:MTH) to Sell
Next post Germany private sales Full Year 2024: VW T-Roc and Dacia Sandero in charge